Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Chulho Oak MD, PhD"'
Autor:
Eunbin Kwag PhD, Soo-Dam Kim MD, PhD, Seong-Hoon Shin MD, PhD, Chulho Oak MD, PhD, So-Jung Park KMD, PhD, Jun-Yong Choi KMD, PhD, Seong Hoon Yoon MD, PhD, In-Cheol Kang PhD, Mi-Kyung Jeong KMD, PhD, Hyun Woo Lee MD, PhD, Sun-Hwi Bang KMD, PhD, Ji Woong Son MD, PhD, Sanghun Lee PhD, Seung Joon Kim MD, PhD, Hwa-Seung Yoo KMD, PhD
Publikováno v:
Integrative Cancer Therapies, Vol 23 (2024)
Background: Lung cancer, especially non-small cell lung cancer (NSCLC), poses a significant health challenge globally due to its high mortality. Afatinib, a second-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), has
Externí odkaz:
https://doaj.org/article/16dc59132dba49268b5fe5b711723fa5